Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
In recognition of American Heart Month, PDS Health™, a leading dental and medical support organization, is raising awareness about the critical link between oral health and heart health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback